| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 4-Ethylaniline |
對乙苯胺 |
589-16-2 |
詳細
|
| Xanomeline Impurity 13 |
呫若美林雜質(zhì)13 |
131987-69-4 |
詳細
|
| Faropenem finished product impurity 22 |
法羅培南成品雜質(zhì)22 |
87024-25-7 |
詳細
|
| Vancomycin Impurity F |
萬古霉素雜質(zhì)F |
2415254-43-0 |
詳細
|
| Benazepril Hydrochloride EDQM System Applicability Reference Standard |
鹽酸貝那普利EDQM系統(tǒng)適用性對照品 |
86541-74-4 |
詳細
|
| Methyl 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxylate |
4-(2R,3S,4S,5R)-3-(3,4-二氟-2-甲氧基苯基)-4,5-二甲基-5-三氟甲基四氫呋喃-2-甲酰胺基吡啶甲酸甲酯 |
2879218-02-5 |
詳細
|
| Pyridinium, 5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-3-hydroxy-1-methyl- |
呫若美林雜質(zhì)7 |
2414049-88-8 |
詳細
|
| Candesartan Cilexetil Impurity H |
坎地沙坦酯雜質(zhì)H |
170791-09-0 |
詳細
|
| Tadalafil iMpurity 17 |
他達拉非雜質(zhì)17 |
951661-84-0 |
詳細
|
| Aztreonam E-Isomer |
氨曲南E異構(gòu)體 |
99341-02-3 |
詳細
|
| Adrenaline Impurity 26（Adrenergic methoxy analogues） |
腎上腺素雜質(zhì)26(腎上腺素甲氧基類似物） |
74571-90-7 |
詳細
|
| Hydrochlorothiazide |
氫氯噻嗪 |
58-93-5 |
詳細
|
| Diclofenac sodium |
雙氯芬酸鈉 |
15307-79-6 |
詳細
|
| 3-Ethylaniline |
間乙苯胺 |
587-02-0 |
詳細
|
| Rebamipide reference standard |
瑞巴派特對照品 |
90098-04-7 |
詳細
|
| Phentolamine mesilate |
甲磺酸酚妥拉明 |
65-28-1 |
詳細
|
| Lorazepam USP Impurity B |
勞拉西泮USP雜質(zhì)B |
2958-36-3 |
詳細
|
| (S)-4-(3-(Benzylthio)phenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride |
(S)-4-(3-(芐硫基)苯基)-6,8-二氯-2-甲基-1,2,3,4-四氫異喹啉鹽酸鹽 |
2322360-87-0 |
詳細
|
| Carbocisteine Impurity 2 |
羧甲司坦雜質(zhì)2 |
5439-87-2 |
詳細
|
| Triacetic Acid Impurity 3 |
三乙酸雜質(zhì)3 |
862542-34-5 |
詳細
|
| Xanomeline Impurity 11 |
呫若美林雜質(zhì)11 |
17604-74-9 |
詳細
|
| 5-Bromo-2-chloropyrimidine |
5-溴-2-氯嘧啶 |
32779-36-5 |
詳細
|
| Perindopril related compound 3 hydrochloride |
培哚普利相關(guān)化合物3鹽酸鹽 |
169061-41-0 |
詳細
|
| Piracetam impurity 1 |
吡拉西坦雜質(zhì)1 |
616-45-5 |
詳細
|
| 5-(4-Bromophenyl)-4,6-dichloropyrimidine |
5-（4-溴苯基）-4,6-二氯嘧啶 |
146533-41-7 |
詳細
|
| NEU1130-VST-IM2 reference standard |
NEU1130-VST-IM2對照品 |
952652-79-8 |
詳細
|
| Roxithromycin EP Impurity G |
羅紅霉素EP雜質(zhì)G |
425365-64-6 |
詳細
|
| Faropenem finished product impurity 24 |
法羅培南成品雜質(zhì)24 |
18173-64-3 |
詳細
|
| Suzetrigine |
舒澤曲近 |
2649467-58-1 |
詳細
|
| Xanomeline Impurity 6 |
呫若美林雜質(zhì)6 |
131986-66-8 |
詳細
|
| 2-Ethylaniline |
鄰乙苯胺 |
578-54-1 |
詳細
|
| Ipratropium Bromide Impurity 22 |
異丙托溴銨雜質(zhì)22 |
88607-15-2 |
詳細
|
| (18β,20α)-Glycyrrhizic acid |
苷草皂苷H2 |
118441-85-3 |
詳細
|
| 4-Nitrobenzenesulfonamide |
4-硝基苯磺酰胺 |
6325-93-5 |
詳細
|
| Cefuroxime Sodium EP Impurity C |
頭孢呋辛鈉EP雜質(zhì)C |
69822-88-4 |
詳細
|
| Intermediate F of Flomoxef |
氟氧頭孢中間體F |
134237-56-2 |
詳細
|
| noradrenaline bitartrate |
重酒石酸去甲腎上腺素 |
110-65-8 |
詳細
|
| (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic dimethylcarbamic thioanhydride |
丙酸氟替卡松中間體III雜質(zhì) |
709002-84-6 |
詳細
|
| Diazoxide reference substance (main component) |
二氮嗪對照品（主成分） |
364-98-7 |
詳細
|
| Polydocanol working reference standard |
聚多卡醇工作對照品 |
3055-99-0 |
詳細
|
| Dolutegravir Impurity F |
多替拉韋鈉雜質(zhì)F |
2244161-72-4 |
詳細
|
| D-Carnitine |
D-肉堿 |
541-14-0 |
詳細
|
| Xanomeline Impurity 14 |
呫若美林雜質(zhì)14 |
131988-19-7 |
詳細
|
| Famotidine Impurity D |
法莫替丁雜質(zhì)D |
76824-16-3 |
詳細
|
| Vancomycin Impurity D |
萬古霉素雜質(zhì)D |
|
詳細
|
| Dolutegravir Impurity L |
多替拉韋鈉雜質(zhì)L |
1206102-11-5 |
詳細
|
| Intermediate of tenapanor |
替納帕諾中間體 |
1234423-95-0 |
詳細
|
| Palonosetron hydrochloride impurity B |
鹽酸帕洛諾司瓊雜質(zhì)B |
|
詳細
|
| Famotidine Impurity A |
法莫替丁雜質(zhì)A |
88061-72-7 |
詳細
|
| Vortioxetine Impurity 54 |
沃替西汀雜質(zhì)54 |
1293489-64-1 |
詳細
|
| Dolutegravir Impurity D |
多替拉韋鈉雜質(zhì)D |
1863916-87-3 |
詳細
|
| Aztreonam Impurity 1 |
|
|
詳細
|
| Cetirizine EP impurity B(deracemization) |
西替利嗪EP雜質(zhì)B(消旋) |
113740-61-7 |
詳細
|
| 3-Hydroxynaphthalene-2,7-disulfonic |
3-羥基-2,7-萘二磺酸鈉 |
135-51-3 |
詳細
|
| Glucose acid impurity 13 |
葡萄糖酸雜質(zhì)13 |
34290-52-3 |
詳細
|
| 2(5H)-Furanone |
2(5H)-呋喃酮 |
497-23-4 |
詳細
|
| Intermediate impurity |
中間體雜質(zhì) |
2875066-56-9 |
詳細
|
| BORIC-10B ACID |
Boric-10 acid (10B, 96%) |
13813-79-1 |
詳細
|
| 11-Oxo-3β-[[2-O-(6-oxo-β-D-glucopyranosyl)-6-oxo-β-D-glucopyranosyl]oxy]-24-hydroxyolean-12-en-30-oic acid |
苷草皂苷G2 |
118441-84-2 |
詳細
|
| 18α-Glycyrrhizic acid |
18a-甘草酸 |
83896-44-0 |
詳細
|
| Deoxyadrenaline hydrochloride |
脫氧腎上腺素鹽酸 |
62-32-8 |
詳細
|
| Dolutegravir Impurity G |
多替拉韋鈉雜質(zhì)G |
1863916-88-4 |
詳細
|
| D65-B interconversion impurity |
D65-B互變雜質(zhì) |
1646862-09-0 |
詳細
|
| Cefazolin Impurity J |
頭孢唑林雜質(zhì)J |
32510-61-5 |
詳細
|
| Carcassone oxide |
氧化卡松 |
948566-13-0 |
詳細
|
| Xanomeline Impurity 2 |
呫若美林雜質(zhì)2 |
131986-96-4 |
詳細
|
| Rocuronium Bromide Impurity 34 |
羅庫溴銨雜質(zhì)50 |
144209-33-6 |
詳細
|
| Dehydro Desloratadine |
脫氫地氯雷他定 |
117811-20-8 |
詳細
|
| Glucose acid impurity 6 |
葡萄糖酸雜質(zhì)6 |
2436275-39-5 |
詳細
|
| Sodium 6-hydroxynaphthalene-2-sulfonate |
6-羥基-2-萘磺酸鈉 |
135-76-2 |
詳細
|
| Vancomycin Impurity E |
萬古霉素雜質(zhì)E |
|
詳細
|
| 2(5H)-Furanone, 3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)-, (5R)- |
3-（3,4-二氟-2-甲氧基苯基）-4,5-二甲基-5-三氟甲基呋喃-2（5H）酮 |
2875066-35-4 |
詳細
|
| Amlodipine Impurity C |
氨氯地平雜質(zhì)C |
721958-74-3 |
詳細
|
| Vancomycin Impurity B |
萬古霉素雜質(zhì)B |
555598-85-1 |
詳細
|
| Lorazepam USP Impurity C |
勞拉西泮USP雜質(zhì)C |
93955-15-8 |
詳細
|
| Tenapanor hydrochloride |
雙鹽酸替那帕諾 |
1234365-97-9 |
詳細
|
| opromide Impurity F |
碘普羅胺雜質(zhì)F |
154361-54-3 |
詳細
|
| Micammonium chloride reference substance |
米庫氯銨對照品 |
|
詳細
|
| Dolutegravir Impurity C |
多替拉韋鈉雜質(zhì)C |
2244161-71-3 |
詳細
|
| 4- (1-Nitrosylhydrazido) - benzenesulfonamide |
4-(1-亞硝基肼基)-苯磺酰胺 |
2860553-70-2 |
詳細
|
| Flusulfonamide API-S |
氟砜草胺API-S |
2421252-74-4 |
詳細
|
| Faropenem finished product impurity 6 |
法羅培南成品雜質(zhì)6 |
|
詳細
|
| Fluticasone Propionate Impurity 100 |
丙酸氟替卡松雜質(zhì)100 |
2408725-66-4 |
詳細
|
| Vancomycin Impurity J |
萬古霉素雜質(zhì)J |
2416251-24-4 |
詳細
|
| Pyrimidine, 5-(4-bromophenyl)-4-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-6-chloro- |
5-(4-溴苯基)-4-(2-[(5-溴嘧啶-2-基)氧基]乙氧基)-6-氯嘧啶 |
1642873-05-9 |
詳細
|
| Ipratropium Bromide Impurity 6 |
異丙托溴銨雜質(zhì)6 |
60251-88-9 |
詳細
|
| Flusulfonamide API-R |
氟砜草胺API-R |
2421252-30-2 |
詳細
|
| Faropenem finished product impurity 17 |
法羅培南成品雜質(zhì)17 |
1177767-30-4 |
詳細
|
| Ethyl analogue
7-Chloro-3-ethyl-2H-1,2,4-Benzothiazine-1,1-dioxide |
乙基類似物
7-氯-3-乙基-2H-1,2,4-苯并噻二嗪-1,1-二氧化物 |
1207-63-2 |
詳細
|
| Xanomeline Impurity 4 |
呫若美林雜質(zhì)4 |
159058-46-5 |
詳細
|
| Cyclopenta[b]pyran-5-heptanoic acid, 2-(1,1-difluoropentyl)octahydro-2-hydroxy-6-oxo-, (2R,4aR,5S,7aR)- |
魯比前列素雜質(zhì)1 |
1808535-45-6 |
詳細
|
| Vancomycin EP Impurity K |
萬古霉素雜質(zhì)K |
99759-13-4 |
詳細
|
| Lorazepam USP Impurity E |
勞拉西泮USP雜質(zhì)E |
773871-49-1 |
詳細
|
| 5-Chloro-2,4-dimethylbenzene-1-thiol |
5-氯-2，4-二甲基苯硫酚 |
1823050-95-8 |
詳細
|
| Dolutegravir Impurity K |
多替拉韋鈉雜質(zhì)K |
|
詳細
|
| Ethylenediamine reference standard |
乙二胺對照品 |
|
詳細
|
| 5-(4-Bromophenyl)-4-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-6-fluoropyrimidine |
5-(4-溴苯基)-4-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-6-氟嘧啶 |
1803092-45-6 |
詳細
|
| Faropenem finished product impurity 3 |
法羅培南成品雜質(zhì)3 |
774505-06-5 |
詳細
|
| Faropenem finished product impurity 2 |
法羅培南成品雜質(zhì)2 |
754152-74-4 |
詳細
|
| Xanomeline Impurity 12 |
呫若美林雜質(zhì)12 |
131988-63-1 |
詳細
|